PRINCETON, NJ -- (MARKET WIRE) -- April 05, 2007 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, will participate in the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference.
